3 Cases Exploring the Spectrum of HIV

Cost: Free registration.

This webinar will be presented by:

Dr. Silvia Guillemi
Dr. Zabrina Brumme
Dr. Mark Hull
Dr. Sarah Stone


At the end of the webinar, participants will be able to:

  • To review a case of a client living with HIV with substance use disorder and suboptimal adherence to antiretrovirals
  • Review a complex case of a client with cognitive decline and detectable HIV plasma viral load
  • Explore a case of acute HIV infection

Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.

Please register for the webinar by clicking the following link:

click here.

This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit.

Please note the session will be recorded and available after the event on the BC-CfE’s website at: education.bccfe.ca/webinars

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. We are looking forward to seeing you there!

Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025